226 related articles for article (PubMed ID: 34137164)
21. Relapsed Osteosarcoma Trial Concepts to Match the Complexity of the Disease.
Reed DR; Hingorani P; Anderson PM
Adv Exp Med Biol; 2020; 1257():85-94. PubMed ID: 32483733
[TBL] [Abstract][Full Text] [Related]
22. An update on chemotherapy for osteosarcoma.
Ferrari S; Serra M
Expert Opin Pharmacother; 2015; 16(18):2727-36. PubMed ID: 26512909
[TBL] [Abstract][Full Text] [Related]
23. Immunotherapy for osteosarcoma: Where do we go from here?
Wedekind MF; Wagner LM; Cripe TP
Pediatr Blood Cancer; 2018 Sep; 65(9):e27227. PubMed ID: 29923370
[TBL] [Abstract][Full Text] [Related]
24. Efficacy of liposomal muramyl tripeptide (CGP 19835A) in the treatment of relapsed osteosarcoma.
Kleinerman ES; Gano JB; Johnston DA; Benjamin RS; Jaffe N
Am J Clin Oncol; 1995 Apr; 18(2):93-9. PubMed ID: 7900714
[TBL] [Abstract][Full Text] [Related]
25. Poor survival for osteosarcoma of the pelvis: a report from the Children's Oncology Group.
Isakoff MS; Barkauskas DA; Ebb D; Morris C; Letson GD
Clin Orthop Relat Res; 2012 Jul; 470(7):2007-13. PubMed ID: 22354612
[TBL] [Abstract][Full Text] [Related]
26. Upfront window trial of topotecan in previously untreated children and adolescents with poor prognosis metastatic osteosarcoma: children's Cancer Group (CCG) 7943.
Seibel NL; Krailo M; Chen Z; Healey J; Breitfeld PP; Drachtman R; Greffe B; Nachman J; Nadel H; Sato JK; Meyers PA; Reaman GH
Cancer; 2007 Apr; 109(8):1646-53. PubMed ID: 17334983
[TBL] [Abstract][Full Text] [Related]
27. Feasibility and dose discovery analysis of zoledronic acid with concurrent chemotherapy in the treatment of newly diagnosed metastatic osteosarcoma: a report from the Children's Oncology Group.
Goldsby RE; Fan TM; Villaluna D; Wagner LM; Isakoff MS; Meyer J; Randall RL; Lee S; Kim G; Bernstein M; Gorlick R; Krailo M; Marina N
Eur J Cancer; 2013 Jul; 49(10):2384-91. PubMed ID: 23664013
[TBL] [Abstract][Full Text] [Related]
28. Phase I/II study of single-agent lenvatinib in children and adolescents with refractory or relapsed solid malignancies and young adults with osteosarcoma (ITCC-050)
Gaspar N; Campbell-Hewson Q; Gallego Melcon S; Locatelli F; Venkatramani R; Hecker-Nolting S; Gambart M; Bautista F; Thebaud E; Aerts I; Morland B; Rossig C; Canete Nieto A; Longhi A; Lervat C; Entz-Werle N; Strauss SJ; Marec-Berard P; Okpara CE; He C; Dutta L; Casanova M
ESMO Open; 2021 Oct; 6(5):100250. PubMed ID: 34562750
[TBL] [Abstract][Full Text] [Related]
29. Current status and perspectives regarding the treatment of osteo-sarcoma: chemotherapy.
Sakamoto A; Iwamoto Y
Rev Recent Clin Trials; 2008 Sep; 3(3):228-31. PubMed ID: 18782081
[TBL] [Abstract][Full Text] [Related]
30. Phase II trial of trastuzumab in combination with cytotoxic chemotherapy for treatment of metastatic osteosarcoma with human epidermal growth factor receptor 2 overexpression: a report from the children's oncology group.
Ebb D; Meyers P; Grier H; Bernstein M; Gorlick R; Lipshultz SE; Krailo M; Devidas M; Barkauskas DA; Siegal GP; Ferguson WS; Letson GD; Marcus K; Goorin A; Beardsley P; Marina N
J Clin Oncol; 2012 Jul; 30(20):2545-51. PubMed ID: 22665540
[TBL] [Abstract][Full Text] [Related]
31. Drugs in early clinical development for the treatment of osteosarcoma.
Heymann MF; Brown HK; Heymann D
Expert Opin Investig Drugs; 2016 Nov; 25(11):1265-1280. PubMed ID: 27633385
[TBL] [Abstract][Full Text] [Related]
32. Zoledronate in combination with chemotherapy and surgery to treat osteosarcoma (OS2006): a randomised, multicentre, open-label, phase 3 trial.
Piperno-Neumann S; Le Deley MC; Rédini F; Pacquement H; Marec-Bérard P; Petit P; Brisse H; Lervat C; Gentet JC; Entz-Werlé N; Italiano A; Corradini N; Bompas E; Penel N; Tabone MD; Gomez-Brouchet A; Guinebretière JM; Mascard E; Gouin F; Chevance A; Bonnet N; Blay JY; Brugières L; ; ;
Lancet Oncol; 2016 Aug; 17(8):1070-1080. PubMed ID: 27324280
[TBL] [Abstract][Full Text] [Related]
33. Targeting the Cancer Epigenome with Histone Deacetylase Inhibitors in Osteosarcoma.
Collier CD; Getty PJ; Greenfield EM
Adv Exp Med Biol; 2020; 1258():55-75. PubMed ID: 32767234
[TBL] [Abstract][Full Text] [Related]
34. Assessment of extent of surgical resection of primary high-grade osteosarcoma by treating institutions: A report from the Children's Oncology Group.
Morris CD; Teot LA; Bernstein ML; Marina N; Krailo MD; Villaluna D; Janeway KA; DuBois SG; Gorlick RG; Randall RL
J Surg Oncol; 2016 Mar; 113(4):351-4. PubMed ID: 26776342
[TBL] [Abstract][Full Text] [Related]
35. Preclinical validation of Aurora kinases-targeting drugs in osteosarcoma.
Tavanti E; Sero V; Vella S; Fanelli M; Michelacci F; Landuzzi L; Magagnoli G; Versteeg R; Picci P; Hattinger CM; Serra M
Br J Cancer; 2013 Nov; 109(10):2607-18. PubMed ID: 24129234
[TBL] [Abstract][Full Text] [Related]
36. Efficacy and safety of regorafenib in adult patients with metastatic osteosarcoma: a non-comparative, randomised, double-blind, placebo-controlled, phase 2 study.
Duffaud F; Mir O; Boudou-Rouquette P; Piperno-Neumann S; Penel N; Bompas E; Delcambre C; Kalbacher E; Italiano A; Collard O; Chevreau C; Saada E; Isambert N; Delaye J; Schiffler C; Bouvier C; Vidal V; Chabaud S; Blay JY;
Lancet Oncol; 2019 Jan; 20(1):120-133. PubMed ID: 30477937
[TBL] [Abstract][Full Text] [Related]
37. Intensified Chemotherapy With Dexrazoxane Cardioprotection in Newly Diagnosed Nonmetastatic Osteosarcoma: A Report From the Children's Oncology Group.
Schwartz CL; Wexler LH; Krailo MD; Teot LA; Devidas M; Steinherz LJ; Goorin AM; Gebhardt MC; Healey JH; Sato JK; Meyers PA; Grier HE; Bernstein ML; Lipshultz SE
Pediatr Blood Cancer; 2016 Jan; 63(1):54-61. PubMed ID: 26398490
[TBL] [Abstract][Full Text] [Related]
38. A phase II trial of second-line pemetrexed in adults with advanced/metastatic osteosarcoma.
Duffaud F; Egerer G; Ferrari S; Rassam H; Boecker U; Bui-Nguyen B
Eur J Cancer; 2012 Mar; 48(4):564-70. PubMed ID: 22243773
[TBL] [Abstract][Full Text] [Related]
39. Micrometastatic Drug Screening Platform Shows Heterogeneous Response to MAP Chemotherapy in Osteosarcoma Cell Lines.
Collier CD; Wirtz EC; Knafler GJ; Morris WZ; Getty PJ; Greenfield EM
Clin Orthop Relat Res; 2018 Jul; 476(7):1400-1411. PubMed ID: 29481344
[TBL] [Abstract][Full Text] [Related]
40. New insights into molecular and cellular mechanisms of zoledronate in human osteosarcoma.
Lu KH; Lu EW; Lin CW; Yang JS; Yang SF
Pharmacol Ther; 2020 Oct; 214():107611. PubMed ID: 32565177
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
